Roland Böttger

Company: CureVac

Job title: Senior Scientist

Seminars:

An mRNA-LNP Vaccine Platform Tailoring the Immunogenicity Profile from Prophylactic to Therapeutic Applications, Reducing Reactogenicity and Extending Shelf-Life Stability 12:30 pm

Addressing shortcomings in the immunogenicity, reactogenicity and stability of current mRNA vaccines by optimizing the lipid nanoparticle components Investigating the addition of targeting lipids to tune the immunogenicity profile towards the requirements of different prophylactic and therapeutic applications Extending the shelf-life of mRNA vaccines by developing lyophilizable LNPs and microneedle-array patchesRead more

day: Conference Day Two